Skip to content
SHM Abstracts | Society of Hospital Medicine Logo
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
Search2020-05-20T12:01:36-05:00
Search
Search by Abstract Number, Title, Keyword, or Authors
Category
Sub-Category

(Optional)

Session Type
Meeting
Search Results for withdrawal
Plenary Presentations
DECREASING ADMISSIONS, READMISSIONS AND LENGTH OF STAY WHILE IMPROVING PATIENT SAFETY FOR ALCOHOL WITHDRAWAL SYNDROME
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: There were nearly 33,000 admissions to Department of Veterans Affairs hospitals for alcohol withdrawal syndrome (AWS) in fiscal year 2017. Symptom-triggered management is the standard of care and, when employed effectively, the number of medication doses during admission is a good proxy for clinical severity of withdrawal. Several evidence-based algorithms for outpatient management of [...]
Oral Presentations
Abstract Number: 15
IMPROVED ALCOHOL USE DISORDER TREATMENT LEADING TO DECREASED READMISSION RATES
SHM Converge 2024
Background: Affecting approximately 5.9% of the US population, alcohol use disorder (AUD) has been established as a prevalent disease in this country (1). Through repeated hospital admissions for alcohol use disorder (including alcohol withdrawal syndromes), hospital costs have steadily risen to recent estimates of 7.6 billion dollars in 2017 (2). Without the establishment of outpatient [...]
Plenary Presentations
DECREASING ADMISSIONS, READMISSIONS AND LENGTH OF STAY WHILE IMPROVING PATIENT SAFETY FOR ALCOHOL WITHDRAWAL SYNDROME
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: There were nearly 33,000 admissions to Department of Veterans Affairs hospitals for alcohol withdrawal syndrome (AWS) in fiscal year 2017. Symptom-triggered management is the standard of care and, when employed effectively, the number of medication doses during admission is a good proxy for clinical severity of withdrawal. Several evidence-based algorithms for outpatient management of [...]
Oral Presentations
Abstract Number: 15
IMPROVED ALCOHOL USE DISORDER TREATMENT LEADING TO DECREASED READMISSION RATES
SHM Converge 2024
Background: Affecting approximately 5.9% of the US population, alcohol use disorder (AUD) has been established as a prevalent disease in this country (1). Through repeated hospital admissions for alcohol use disorder (including alcohol withdrawal syndromes), hospital costs have steadily risen to recent estimates of 7.6 billion dollars in 2017 (2). Without the establishment of outpatient [...]
Abstract Number: 20
AN INNOVATIVE ALCOHOL WITHDRAWAL PROTOCOL REDUCES LENGTH OF STAY, RESTRAINT USE, AND TRANSFERS TO INTENSIVE CARE
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Alcohol withdrawal is a common disorder faced by hospitalists. The pharmacologic standard of care involves the use of benzodiazepines, administered either as fixed doses or with doses adjusted per patient symptoms. At our institution, the alcohol withdrawal protocol previously in place used an institution-specific scale to evaluate patient symptoms, and nurses had latitude within [...]
Abstract Number: 44
PHENOBARBITAL VS. SYMPTOM TRIGGERED LORAZEPAM FOR ALCOHOL WITHDRAWAL ON GENMED
SHM Converge 2023
Background: Alcohol withdrawal is a common issue in hospitalized patients and is associated with significant morbidity and mortality. Alcohol withdrawal occurs when the gamma aminobutyric acid (GABA) stimulating effect of alcohol is removed, resulting in an excess of the excitatory neurotransmitter glutamate. Treatment typically consists of as needed benzodiazepines, which activate GABA. However, this reactive [...]
Abstract Number: 46
LENGTH OF SURVIVAL AFTER VENTILATOR WITHDRAWAL IN AN URBAN MINORITY COMMUNITY HOSPITAL
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Vent withdrawal (VW) is a procedure offered when an intubated patient fails to demonstrate meaningful recovery, the patient is not likely to survive given the extent or burden of underlying medical conditions, or patient’s best anticipated outcome from ongoing ventilator support is inconsistent with patient’s known or presumed wishes. Comfort of the patient after [...]
Abstract Number: 135
PHOSPHATIDYLETHANOL LEVEL AS A PREDICTOR OF ACUTE ALCOHOL WITHDRAWAL
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Acute alcohol withdrawal syndrome (AWS) is a common complication in hospitalized patients, but its occurrence and severity is difficult to predict based on clinical indicators alone. Phosphatidylethanol (PEth) is an abnormal phospholipid incorporated into erythrocyte lipid bilayers in proportion to levels of alcohol exposure, with a half-life of 5 to 10 days. We sought [...]
Abstract Number: 138
A COMPARISON OF BAWS (BRIEF ALCOHOL WITHDRAWAL SCALE) WITH CIWA-AR TO DIAGNOSE THE SEVERITY OF ALCOHOL WITHDRAWAL IN HOSPITALIZED MEDICAL PATIENTS
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Treating alcohol withdrawal in the inpatient medical setting requires timely identification of the severity of alcohol withdrawal so appropriate treatment can be administered. Delayed or missed diagnosis can lead to increased morbidity and mortality, increased cost and length of stay, and ICU admissions. CIWA-Ar is the most commonly used scale, but it is lengthy [...]
Abstract Number: 145
COMPARISON OF PHENOBARBITAL AND LORAZEPAM PROTOCOLS FOR INPATIENT ALCOHOL WITHDRAWAL SYNDROME; A RETROSPECTIVE COHORT STUDY
SHM Converge 2024
Background: Alcohol use disorder (AUD) Is present in 10% of adults and its prevalence is increasing. When patients with AUD are admitted to the hospital, half develop alcohol withdrawal syndrome (AWS), which can cause delirium, hallucinations, seizures, and even mortality if not treated appropriately. A fixed-dose phenobarbital strategy may be superior to the standard of [...]
1 2 3 4 Next ›
  • This Week

  • This Month

  • All Time

  • This Week

  • FEEDBACK THAT WORKS: IMPROVED BILLING THROUGH AUTOMATED PEER COMPARISON

  • NALTREXONE – INDUCED KRATOM WITHDRAWAL: A CALL FOR AWARENESS

  • A CASE OF AMANTADINE INDUCED LIVEDO RETICULARIS IN A PATIENT WITH MULTIPLE SCLEROSIS

  • LOSARTAN-INDUCED ELECTROLYTE DEPLETION

  • Cannabis Withdrawal Induced Hypertensive Urgency

  • This Month

  • FEEDBACK THAT WORKS: IMPROVED BILLING THROUGH AUTOMATED PEER COMPARISON

  • NALTREXONE – INDUCED KRATOM WITHDRAWAL: A CALL FOR AWARENESS

  • A CASE OF AMANTADINE INDUCED LIVEDO RETICULARIS IN A PATIENT WITH MULTIPLE SCLEROSIS

  • LOSARTAN-INDUCED ELECTROLYTE DEPLETION

  • Cannabis Withdrawal Induced Hypertensive Urgency

  • All Time

  • FEEDBACK THAT WORKS: IMPROVED BILLING THROUGH AUTOMATED PEER COMPARISON

  • ADDERALL INDUCED ISCHEMIC COLITIS

  • A CASE OF SKIN NECROSIS CAUSED BY INTRAVENOUS XYLAZINE ABUSE

  • Bc Powder Causing Intracerebral Bleed: Pitfalls of Overlooking Dosage of Seemingly Innocuous Otc Formulations

  • RECOGNIZING S1Q3T3 FOR WHAT IT IS: A NONSPECIFIC PATTERN OF RIGHT HEART STRAIN

© Society of Hospital Medicine | All Rights Reserved | Privacy Policy
Page load link
Go to Top